NEW YORK CITY, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

Y Intercept Hong Kong Ltd lessened its stake in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 47.1% in the fourth ...

Experience the breathtaking arrival and sailaway of Carnival Celebration in St. Thomas from the comfort of your balcony ...

We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going ...

Turning Point Brands Inc (TPB) is expected to report $0.69 for 4Q. VYNE Therapeutics Inc (VYNE) is expected to report $-0.29 for 4Q. Werewolf Therapeutics Inc (HOWL) is expected to report $-0.43 for ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

In a report released on February 28, Eric Joseph from J.P. Morgan maintained a Buy rating on Akero Therapeutics (AKRO – Research Report), with ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against the other biotech stocks. No matter the market environment, you’ll always find ...

A number of research analysts recently issued reports on AKRO shares. Morgan Stanley boosted their price target on Akero Therapeutics from $46.00 to $96.00 and gave the company an “overweight ...

FAA workers threatened with firing if they ‘impede’ Elon Musk’s SpaceX federal deal: Report - Elon Musk has been at the ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other ...